Table 7.
Impact of different medications on QLQ of breast cancer patients based on QLQ-BR-23 scales
| QLQ-BR-23 scales | QOL | P value | ||
|---|---|---|---|---|
| Conventional therapy | Hormonal therapy | Targeted therapy | ||
| Functional scales | ||||
| Body image | 47.85 ± 3.9 | 47.94 ± 4.0 | 45.24 ± 9.5 | 0.97 |
| Future perspective | 72.70 ± 3.7 | 75.31 ± 3.6 | 85.72 ± 8.3 | 0.436 |
| Symptom scales | ||||
| Systemic therapy side effects | 49.22 ± 2.3 | 17.75 ± 1.7 | 26.53 ± 5.7 | 0.000*** |
| Breast symptoms | 26.27 ± 2.2 | 28.09 ± 2.4 | 21.43 ± 4.0 | 0.568 |
| Arm symptoms | 17.88 ± 2.0 | 41.57 ± 2.7 | 43.66 ± 7.4 | 0.000*** |
| Upset by hair loss | 67.72 ± 3.5 | 37.49 ± 8.5 | 33.34 ± 14.9 | 0.001** |
**P ≤ 0.01; ***P ≤ 0.001